Skip to main content

Table 4 Multivariate analysis of recurrence-free survival between patients treated with tamoxifen (TAM) and toremifene (TOR)

From: A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study

  HR (95%CI) P value
Age 0.960(0.903-1.020) 0.191
T 1.602(0.844-3.041) 0.150
Grade 0.817(0.547-1.220) 0.323
N 1.543(0.998-2.385) 0.051
Her-2 0.950(0.856-1.055) 0.336
Local control 0.933(0.521-1.672) 0.816
Chemotherapy 1.249(0.898-1.739) 0.187
TAM-TOR 0.385(0.154-0.961) 0.041